Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
How would you treat a head and neck patient who had definitive chemoradiation who develops an isolated mediastinal lymph node recurrence?
Do you offer definitive treatment?
Systemic therapy alone since it's metastatic?
Answer from: Radiation Oncologist at Academic Institution
45 Gy/25 fx to mediastinum and boost to positive node to 65 to 70 Gy.
Comments
Radiation Oncologist at Karmanos Cancer Institute - McLaren Proton Therapy Center
I agree with Dr. @William M. Mendenhall, treat for...
5546
Sign in or Register to read more
11759
Related Questions
Is there a role for radiation in biphenotypic sinonasal sarcoma?
How do you consider the role of probiotics for mucositis mitigation in patients receiving head and neck radiotherapy?
Are any centers routinely using 55 Gy in 20 fractions with chemotherapy for definitive treatment of head and neck cancer following presentation of the HYPNO study?
How would you approach SCC of unknown primary, p16-, EBV-, metastatic to a large 5.5 cm level 2 neck node, if you suspect a cutaneous origin after clinical workup?
In what cases of T3N0 glottic SCC, would you omit chemotherapy and offer radiation alone?
Would you modify your treatment approach for treating an HPV-positive head and neck cancer in a patient with symptomatic Sjogren's?
What is your approach to managing asymptomatic ORN of the mandible?
When would you consider larynx preservation in patients with T4N+ SCC of the larynx?
For locally advanced adenocarcinoma of the maxillary sinus, how should the neck be managed?
How would you approach an early stage p16+ SCC of the tonsil s/p TORS and neck dissection with initial positive margins but then negative on re-resection?
I agree with Dr. @William M. Mendenhall, treat for...